These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 769679)

  • 21. In vitro activity of cefaclor, a new orally administered cephalosporin antibiotic.
    Santoro J; Levison ME
    Antimicrob Agents Chemother; 1977 Sep; 12(3):442-3. PubMed ID: 907337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cefoxitin activity against multiply antibiotic-resistance Klebsiella pneumoniae in vitro.
    Jackson RT; Thomas FE; Alford RH
    Antimicrob Agents Chemother; 1977 Jan; 11(1):84-7. PubMed ID: 319753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of the in vitro activity of cefoxitin and cephalothin against 7,312 clinical isolates.
    Lingaas E; Midtvedt T; Melby K; Dahl OU
    Chemotherapy; 1981; 27(4):239-46. PubMed ID: 7249786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro evaluation of cefoxitin and cefamandole.
    Adams HG; Stilwell GA; Turck M
    Antimicrob Agents Chemother; 1976 Jun; 9(6):1019-24. PubMed ID: 820241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity and pharmacokinetics in patients of cefamandole, a new cephalsoporin antibiotic.
    Shemonsky NK; Carrizosa J; Levison ME
    Antimicrob Agents Chemother; 1975 Dec; 8(6):679-83. PubMed ID: 1211920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity and beta-lactamase stability of cefazaflur compared with those of beta-lactamase-stable cephalosporins.
    Aswapokee N; Neu HC
    Antimicrob Agents Chemother; 1979 Mar; 15(3):444-6. PubMed ID: 313753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibacterial activity of cefamandole in vitro.
    Meyers BR; Hirschman SZ
    J Infect Dis; 1978 May; 137 Suppl():S25-S31. PubMed ID: 349095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Concept of class in relation to first-generation cephalosporins].
    De Toffoli A; Fantin B; Vechiet D
    Quad Sclavo Diagn; 1984 Jun; 20(2):181-6. PubMed ID: 6441962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative in vitro study in new cephalosporins.
    Bodey GP; Fainstein V; Hinkle AM
    Antimicrob Agents Chemother; 1981 Aug; 20(2):226-30. PubMed ID: 7283419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro antibacterial activity of moxalactam, a new broad-spectrum semisynthetic antibiotic.
    Skalova R; Hajsig D; Muic V; Kapun D
    Infection; 1980; 8 Suppl 3():S 330-3. PubMed ID: 6447672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo antibacterial properties of FK 027, a new orally active cephem antibiotic.
    Kamimura T; Kojo H; Matsumoto Y; Mine Y; Goto S; Kuwahara S
    Antimicrob Agents Chemother; 1984 Jan; 25(1):98-104. PubMed ID: 6561017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
    Hall WH; Opfer BJ; Gerding DN
    Antimicrob Agents Chemother; 1980 Feb; 17(2):273-9. PubMed ID: 6247970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Susceptibility of "enterobacteria" to penicillins, cephalosporins, lincomycins, erythromycin, and rifampin.
    Finland M; Garner C; Wilcox C; Sabath LD
    J Infect Dis; 1976 Aug; 134 Suppl():S75-96. PubMed ID: 823280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of in vitro antibacterial activity of four oral cephems: cephalexin, cefaclor, cefatrizine and cefadroxil.
    Luh KT; Chao HP; Ho SW; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1984 Feb; 17(1):11-8. PubMed ID: 6378550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The in vitro spectrum of the cephalosporins.
    Washington JA
    Mayo Clin Proc; 1976 Apr; 51(4):237-50. PubMed ID: 1263595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative bactericidal effect of ceforanide (BL-S 786) and five other cephalosporins in an in vitro pharmacokinetic model.
    Randolph JA; Buck RE; Price KE; Leitner F
    J Antibiot (Tokyo); 1979 Jul; 32(7):727-33. PubMed ID: 396292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of moxalactam against pathogenic bacteria and its comparison with other antibiotics.
    Perrymann F; Flournoy DJ; Qadri SM
    Chemotherapy; 1983; 29(1):37-42. PubMed ID: 6219865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BL-S786 (ceforanide), a new parenteral cephalosporin: in vitro studies.
    Weaver SS; LeBlanc BM; Bodey GP
    Antimicrob Agents Chemother; 1979 Feb; 15(2):318-22. PubMed ID: 426520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activity of BL-s640 against gram-negative bacilli and Staphylococcus aureus compared with activity of four other semisynthetic cephalosporins.
    Vuye A; Pijck J; Soep H
    Antimicrob Agents Chemother; 1976 Mar; 9(3):422-32. PubMed ID: 1259401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug susceptibility-resistance pattern of gram-negative uropathogens to seven cephalosporins.
    Seneca H
    Am J Med Sci; 1973 Nov; 266(5):381-5. PubMed ID: 4202701
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.